ClearBridge Investments
ITCI

ClearBridge Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,686,384
Closed -$141M 753
2024
Q4
$141M Sell
1,686,384
-43,345
-3% -$3.62M 0.11% 181
2024
Q3
$127M Buy
1,729,729
+8,119
+0.5% +$594K 0.1% 200
2024
Q2
$118M Sell
1,721,610
-22,941
-1% -$1.57M 0.1% 201
2024
Q1
$121M Buy
1,744,551
+191,416
+12% +$13.2M 0.1% 225
2023
Q4
$111M Buy
1,553,135
+149,534
+11% +$10.7M 0.1% 223
2023
Q3
$73.1M Sell
1,403,601
-10,144
-0.7% -$528K 0.07% 254
2023
Q2
$89.5M Buy
1,413,745
+363,870
+35% +$23M 0.08% 241
2023
Q1
$56.9M Buy
1,049,875
+390,493
+59% +$21.1M 0.05% 295
2022
Q4
$34.9M Buy
659,382
+8,099
+1% +$429K 0.03% 375
2022
Q3
$30.3M Buy
651,283
+446,112
+217% +$20.8M 0.03% 379
2022
Q2
$11.7M Sell
205,171
-35,257
-15% -$2.01M 0.01% 518
2022
Q1
$14.7M Sell
240,428
-90,742
-27% -$5.55M 0.01% 522
2021
Q4
$17.3M Sell
331,170
-102,148
-24% -$5.35M 0.01% 502
2021
Q3
$16.2M Sell
433,318
-40,075
-8% -$1.49M 0.01% 526
2021
Q2
$19.3M Sell
473,393
-2,119
-0.4% -$86.5K 0.01% 519
2021
Q1
$16.1M Sell
475,512
-146,233
-24% -$4.96M 0.01% 521
2020
Q4
$19.8M Sell
621,745
-24,776
-4% -$788K 0.02% 470
2020
Q3
$16.6M Buy
646,521
+20,379
+3% +$523K 0.01% 457
2020
Q2
$16.1M Buy
626,142
+114,764
+22% +$2.95M 0.01% 443
2020
Q1
$7.86M Buy
511,378
+193,769
+61% +$2.98M 0.01% 508
2019
Q4
$10.5M Sell
317,609
-467,529
-60% -$15.5M 0.01% 542
2019
Q3
$5.87M Buy
+785,138
New +$5.87M 0.01% 577